3,7-DIAMINO-10H-PHENOTHIAZINE SALTS AND THEIR USE
First Claim
1. A compound selected from compounds of the following formula and pharmaceutically acceptable salts, solvates, and hydrates thereof:
3 Assignments
0 Petitions
Accused Products
Abstract
This invention pertains generally to the field of phenothiazine compounds, and more particularly to certain stably reduced phenothiazine compounds, specifically, certain 3,7 diamino-10H-phenothiazine (DAPTZ) compounds of the following formula wherein: each of R1 and R9 is independently selected from: —H; C1-4alkyl; C2-4alkenyl; and halogenated C1-4alkyl; each of R3NA and R3NB is independently selected from: —H; C1-4alkyl; C2-4alkenyl; and halogenated C1-4alkyl; each of R7NA and R7NB is independently selected from: —H; C1-4alkyl; C2-4alkenyl; and halogenated C1-4alkyl; each of HX1 and HX2 is independently a protic acid; and pharmaceutically acceptable salts, solvates, and hydrates thereof. These compounds are useful as drugs, for example, in the treatment of tauopathies, such as Alzheimer'"'"'s disease, and also as prodrugs for the corresponding oxidized thioninium drugs (for example, methythioninium chloride, MTC).
-
Citations
66 Claims
- 1. A compound selected from compounds of the following formula and pharmaceutically acceptable salts, solvates, and hydrates thereof:
-
23. (canceled)
-
26. (canceled)
-
29. (canceled)
-
32-49. -49. (canceled)
- 61. A pharmaceutical composition comprising a compound of the following formula:
- 64. A pharmaceutical composition comprising a compound of the following formula:
Specification